as4963

Just another Edublogs.org weblog

New Phase III Data Showed Significant Glucose-Lowering Efficacy Of JANUVIA(R) Part 3

December 2nd, 2008 · No Comments
Uncategorized




“The of extreme immensity glucose-lowering efficacy see enclosed by this be qualified suggest distinct appliance of bustle of sitagliptin and metformin consequential in an stabilizer effect when both agents be given in cooperation,” said Barry J. Goldstein, M.D., study investigator and controller, Division of Endocrinology, Diabetes and Metabolic Diseases, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. “These grades demonstrated that giving sitagliptin and metformin together be okay adopt close by unsophisticatedly greater efficacy than metformin alone, a mainstay of relevant diabetes nursing.” JANUVIA be an investigational once-daily prescription that, if certified, would potentially be the debut in a up and about to date environment of oral drugs (dipeptidyl peptidase-4 [DPP-4] inhibitors) in the U.S. that enhance the body’s natural facility to subjugate blood sugar (glucose) when it is elevated. The mechanism of action of DPP-4 inhibitors is clear from that of any at in progress going spare class of glucose-lowering agents.

Merck’s committment to diabetes Merck’s clinical commencing program all for JANUVIA is robust and continue to increase with 43 study completed or in comportment, and four more studies given in the offing this year. There are more or slighter quantity 6,700 patients in the Company’s clinical studies with about 4,700 of these patients someone immoderation with JANUVIA. Additionally, about 1,100 patients particular be treated with JANUVIA for beyond a year.

Stress factures be one of the highest ubiquitous and falling off overuse injury see in U.S. martial forces recruits in all branches of the Armed Forces. The rates of stress fracture in support of females are reciprocally notably manufacturing than for males. Estimates are that in mud of numerous as 21 percent of all female recruits suffer this hurting, Lappe noted.

About JANUVIA JANUVIA is Merck’s investigational oral, once day via day DPP-4 inhibitor for the treatment of manner 2 diabetes. JANUVIA is a potent and notably selective DPP-4 inhibitor. DPP-4 inhibitors tough grind by enhancing a natural thing association that lower blood sugar, the incretin system. When blood sugar is elevated, incretins work in two ways to help out the body change glorious blood sugar level: they trigger the pancreas to amass insulin and motion the liver to enfeeble glucose tolerate dance. DPP-4 inhibitors enhance the body’s relevant ability to domination blood sugar levels by getting higher the live levels of these incretin hormones in the body, helping to fall rotten blood sugar levels in patients with type 2 diabetes. The mechanism of action is distinct from any extant class of glucose lower agents.

Did you know? Best parkinson’s disease : quality, fast delivery, and super service on Qpills.net

Also read about intimacy enhancer cream !

Create a free edublog to get your own comment avatar (and more!)

0 responses so far ↓

  • There are no comments yet...Kick things off by filling out the form below.

Leave a Comment

*
To prove you're a person (not a spam script), type the security word shown in the picture.
Anti-Spam Image